| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3036433 | Brain and Development | 2016 | 5 Pages |
Abstract
IMZ-SPECT findings demonstrated reduced benzodiazepine receptor binding and its dynamic changes in an SSADH-deficient patient. Considering the down regulation of the GABAA receptor, ketamine should be included in pharmacotherapeutic strategies for treatment of refractory status epilepticus in SSADH-deficient patients.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Asako Horino, Hisashi Kawawaki, Masataka Fukuoka, Hitomi Tsuji, Yuka Hattori, Takeshi Inoue, Megumi Nukui, Ichiro Kuki, Shin Okazaki, Kiyotaka Tomiwa, Shinichi Hirose,